The impact of the COVID-19 pandemic on lung cancer patients

Zhou, Sha; Chang, Ke-Jie; Mi, Jiaoping; Liang, Zhongxing; Hu, Liyang; Long, Fengjiao; Shi, Haiyan; Lin, Zhong Qiu; Wang, Xiaojin; Pei, Xin

doi:10.21037/apm-20-1662

Cited by 43 publications

(34 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…55 While data demonstrating the effect of COVID-19 specifically on lung cancer research is scant, several studies show that cancer research in general has been compromised. [56][57][58][59][60][61][62][63] Cancer clinical trials have been at the focus of these studies, but it is essential to highlight that translational and observational studies have also been affected. 57 The mechanisms by which research has been compromised include decreased funding, operational concerns with tissue collection and biobanking, holds on clinical trials, reduced workforce, and reduced networking opportunities for international collaborations.…”

Section: Impact Of Covid-19 Pandemic On Lung Cancer Researchmentioning

confidence: 99%

Severity of COVID-19 in patients with lung cancer: evidence and challenges

Passaro

Bestvina

Velez

et al. 2021

J Immunother Cancer

View full text Add to dashboard Cite

Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts with the healthcare system, immunocompromised state from cancer or its therapies, supportive medications such as steroids and most importantly their advanced age and comorbidities. Patients with lung cancer have consistently been reported to suffer from an increased risk of death compared with other cancers. This is possibly due to the combination of specific pathophysiological aspects, including underlying pulmonary compromise due to smoking history and the increased specific pressures on respiratory healthcare services caused by the related pandemic. Rationally and safely treating patients with lung cancer during the pandemic has become a continuous challenge over the last year. Deciding whether to offer, modify, postpone or even cancel treatments for this particular patient’s population has become the crucial recurrent dilemma for lung cancer professionals. Chemotherapy, immunotherapy and targeted agents represent distinct risks factors in the context of COVID-19 that should be balanced with the short-term and long-term consequences of delaying cancer care. Despite the rapid and persistent trend of the pandemic, declared by WHO on March 11, 2020, and still ongoing at the time of writing (January 2021), various efforts were made by oncologists worldwide to understand the impact of COVID-19 on patients with cancer. Adapted recommendations of our evidence-based practice guidelines have been developed for all stakeholders. Different small and large-scale registries, such as the COVID-19 and Cancer Consortium (CCC19) and Thoracic Cancers International COVID-19 Collaboration quickly collected data, supporting cancer care decisions under the challenging circumstance created by the COVID-19 pandemic. Several recommendations were developed as guidance for prioritizing the various aspects of lung cancer care in order to mitigate the adverse effects of the COVID-19 healthcare crisis, potentially reducing the morbidity and mortality of our patients from COVID-19 and from cancer. These recommendations helped inform decisions about treatment of established disease, continuation of clinical research and lung cancer screening. In this review, we summarize available evidence regarding the direct and indirect impact of the COVID-19 pandemic on lung cancer care and patients.

show abstract

Section: Impact Of Covid-19 Pandemic On Lung Cancer Researchmentioning

confidence: 99%

Severity of COVID-19 in patients with lung cancer: evidence and challenges

Passaro

Bestvina

Velez

et al. 2021

J Immunother Cancer

View full text Add to dashboard Cite

show abstract

“…Sha et al first investigated the impact of COVID-19 on non-COVID-19 lung cancer patients during the pandemic. The study demonstrated the significant impact of the COVID-19 crisis on oncological care, indicating that treatment decisions, follow-up and psycho-oncological support need to be changed during pandemic [19]. A study done by a Korean group analyzed the impact of COVID-19 on lung cancer diagnosis in Korea, where lung cancer incidence continues to rise, and they found that the proportion of patients with advanced non-small-cell lung carcinoma (NSCLC) increased during the COVID-19 pandemic [20].…”

Section: The Mortality Of Lung Cancer Patients May Increase Once Infementioning

confidence: 97%

“…Since the outbreak of 2019 novel coronavirus disease (COV-ID- 19) induced by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic has become a global catastrophe resulting in overwhelming impacts on human life [1,2]. In an effort to prevent the spread of the COVID-19, various activities and academic events including cancer medicare, research and academic conferences have been highly interrupted [3].…”

Section: Introductionmentioning

confidence: 99%

The Impact of COVID-19 Pandemic on Lung Cancer Community

Zhang

Zhao

2021

World J Oncol

View full text Add to dashboard Cite

Since the outbreak of 2019 novel coronavirus disease (COVID-19) induced by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic has become a global catastrophe. Patients with cancer especially lung cancer are more vulnerable and susceptible to get infected by the virus SARS-CoV-2. The overwhelming impact of COVID-19 on lung cancer community may result in rise of the incidence and mortality of lung cancer. It would become more obvious in future retrospective studies. Lung cancer patients are believed at higher risk of COVID-19 due to immunosuppression and should be protected by vaccination with priority. Better understanding of SARS-CoV-2 could help develop more effective vaccines to eradicate this disease in the near future.

show abstract

“…During COVID-19 pandemic anxiety of oncologic patients has grown and often resulted in requested therapy delays. With the delays in therapy, the risk of tumour progression rises and threatens the life safety of patients [38,39].…”

Section: Lung Cancer Management During Pandemicmentioning

confidence: 99%

Situation of oncological patients during COVID-19 pandemic with particular emphasis on lung cancer patients

Pytka¹,

Oszczędłowski²,

Nowaczek³

et al. 2021

J Educ Health Sport

View full text Add to dashboard Cite

Introduction and purpose: The purpose of this study is to review literature about alterations to treatment regimens to lung cancer during COVID-19 pandemic accessible on PubMed platform. In pulmonary neoplasms, early diagnosis and treatment is a key to ensure patient safety. Burdening of healthcare systems during pandemic has resulted in many obstacles in oncologic treatment. A brief description of the state of knowledge: The lung cancer is the most frequent and the most deadly cancer in men and women. COVID-19 is a pulmonary infectious disease whose spread around the world has resulted in a pandemic. At the onset of the worldwide pandemic, many institutions, including healthcare facilities were closed, making it more difficult to provide oncological patients the treatment compliant with the standards. The anxiety of patients caused by the pandemic has caused delays in treatment that can cause progression of the disease. In patients with lung cancer mortality of COVID-19 was around 50%, which made their visits at hospital hazardous. Before the accessibility of anti-COVID-19 vaccines telemedical healthcare was one of the ways to provide healthcare to oncological patients. Conclusions: Patients with lung cancer are one of the risk groups of COVID-19. Delays in their treatment caused by the pandemic are potentially dangerous and negatively affect the therapy. Telemedicine is a useful too provide medical care, but has its own limitations.

show abstract

The impact of the COVID-19 pandemic on lung cancer patients

Cited by 43 publications

References 4 publications

Severity of COVID-19 in patients with lung cancer: evidence and challenges

Severity of COVID-19 in patients with lung cancer: evidence and challenges

The Impact of COVID-19 Pandemic on Lung Cancer Community

Situation of oncological patients during COVID-19 pandemic with particular emphasis on lung cancer patients

Contact Info

Product

Resources

About